Schedule 13D - Activist Investments
Jack Harry Kaye consolidates over 10.2 million Davion Healthcare shares into his personal name, maintaining his 41.08% stake.
CEO Jack Kaye and his controlled entities have disclosed a 42% beneficial ownership stake in Davion Healthcare PLC.